What question did this study set out to answer?

To evaluate the efficacy and safety of phosphodiesterase-5 inhibitors (PDE5i) in treating erectile dysfunction following radiotherapy for prostate cancer.

December 5, 2012Urologia Internationalis

Phosphodiesterase-5 Inhibitors Could Be Efficacious in the Treatment of Erectile Dysfunction after Radiotherapy for Prostate Cancer: A Systematic Review and Meta-Analysis

View Full Paper

Ask AI

Bookmark

To evaluate the efficacy and safety of phosphodiesterase-5 inhibitors (PDE5i) in treating erectile dysfunction following radiotherapy for prostate cancer.
Conducted a systematic search across PubMed, Embase, and the Cochrane Library to identify randomized controlled trials evaluating PDE5 inhibitors against placebo in post-radiotherapy prostate cancer patients.
Analyzed outcome metrics including the International Index of Erectile Function (IIEF), Global Efficacy Questions (GEQs), Sexual Encounter Profile (SEP) diaries, and adverse events using RevMan 5.1.4.
Across 4 identified randomized controlled trials, PDE5 inhibitors significantly improved IIEF scores (excluding questions 6 and 13) and yielded statistically significantly more positive responses on GEQs and SEP diaries compared to placebo.
Reported side effects were predominantly mild to moderate, transient, and well tolerated, with only headache, flushing, and dyspepsia occurring at significantly higher rates in the intervention group.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Systematic review and meta-analysis reveals phosphodiesterase-5 inhibitors improve erectile function after prostate cancer radiotherapy, supporting their use as first-line therapy.

Cite This Study

Yang et al. (2012) studied this question.

synapsesocial.com/papers/6a7d4e35b81ad323616e43bc https://doi.org/10.1159/000343730

View Full Paper

Ask AI

Bookmark

Implication

Systematic review and meta-analysis reveals phosphodiesterase-5 inhibitors improve erectile function after prostate cancer radiotherapy, supporting their use as first-line therapy.

Phosphodiesterase-5 Inhibitors Could Be Efficacious in the Treatment of Erectile Dysfunction after Radiotherapy for Prostate Cancer: A Systematic Review and Meta-Analysis

Key Points

Discussion

Implication

Cite This Study

Phosphodiesterase-5 Inhibitors Could Be Efficacious in the Treatment of Erectile Dysfunction after Radiotherapy for Prostate Cancer: A Systematic Review and Meta-Analysis

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider